Search
Filter Results
- Resource Type
- Article1
- Atlases, Pictorial1
- Book1
- Book Digital1
- Article Type
- Research Support, U.S. Gov't, Non-P.H.S.1
- Research Support, U.S. Gov't, P.H.S.1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Cancer1
Search Results
Sort by
- BookLee L.Q. Pu and Nolan S. Karp.Contents:
Breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous (tram) flap
Free or free muscle-sparing tram flap breast reconstruction
Free DIEP flap breast reconstruction
Free SIEA flap breast reconstruction
Free gluteal perforator flap breast reconstruction
Free profunda artery perforator flap breast reconstruction
Free transverse upper gracilis flap breast reconstruction
Latissimus dorsi flap breast reconstruction
Immediate implant breast reconstruction: one-stage
Immediate two-stage implant-based breast reconstruction with acellular dermal matrix
Immediate implant breast reconstruction with total muscle coverage: two-stage
Immediate prepectoral implant breast reconstruction
Delayed two-stage implant-based breast reconstruction
Implant breast reconstruction: revision
Partial breast reconstruction with flaps
Partial breast reconstruction with local tissue rearrangements
Partial breast reconstruction with oncoplastic techniques
Symmetry procedures in breast reconstruction
Fat grafting for total breast reconstruction
Fat grafting as an adjunct procedure in breast reconstruction - Nipple-areola complex reconstruction
Nipple-sparing mastectomy
Correction of Poland syndrome breast deformity
Correction of tuberous breast deformity.Digital Access ClinicalKey 2020 - ArticleSchrek R, Molnar Z, Stefani SS.Cancer. 1978 May;41(5):1845-56.Viable cell suspensions were prepared from 31 nodes diagnosed non-Hodgkin's malignant lymphoma, and from 30 non-malignant nodes. The cells were examined and counted by phase contrast microscopy. The suspensions were characterized by the percentage of large cells and by a colchicine-sensitivity index. The finding of more than 6% large cells or the finding of a sensitivity index of more than 30% was considered a positive test for a malignant lymphoma. According to these criteria there were 2 false positives in 30 reactive nodes and one false negative in 31 malignant nodes. Findings on 3 nodes diagnosed angioimmunoblastic lymphadenopathy suggested malignancy. The colchicinesensitivity index of blood lymphocytes seemed useful for monitoring lymphoma patients for leukemic involvement.